Investigation of drugs affecting hypertension in bevacizumab‐treated patients and examination of the impact on the therapeutic effect
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3587
Abstract: In patients treated with bevacizumab, hypertension may be a biomarker of therapeutic efficacy. However, it is not clear whether drugs that control blood pressure influence bevacizumab's efficacy. In this study, we investigated drugs that may… read more here.
Keywords: bevacizumab; impact therapeutic; hypertension bevacizumab; bevacizumab treated ... See more keywords
Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Future Science OA"
DOI: 10.2144/fsoa-2021-0162
Abstract: Purpose: Inflammatory indexes, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII) and lymphocyte-to-monocyte ratio (LMR), have been confirmed as prognostic factors in multiple manigances. However, the prognostic value of these parameters in… read more here.
Keywords: lung cancer; bevacizumab treated; non small; inflammatory indexes ... See more keywords